25 XP   0   0   10

Ardelyx Inc
Buy, Hold or Sell?

Let's analyse Ardelyx together

PenkeI guess you are interested in Ardelyx Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ardelyx Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ardelyx Inc

I send you an email if I find something interesting about Ardelyx Inc.

Quick analysis of Ardelyx (30 sec.)










What can you expect buying and holding a share of Ardelyx? (30 sec.)

How much money do you get?

How much money do you get?
$0.11
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$0.72
Expected worth in 1 year
$1.01
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$0.41
Return On Investment
6.3%

For what price can you sell your share?

Current Price per Share
$6.48
Expected price per share
$4.97 - $8.16
How sure are you?
50%

1. Valuation of Ardelyx (5 min.)




Live pricePrice per Share (EOD)

$6.48

Intrinsic Value Per Share

$-4.58 - $-0.68

Total Value Per Share

$-3.87 - $0.04

2. Growth of Ardelyx (5 min.)




Is Ardelyx growing?

Current yearPrevious yearGrowGrow %
How rich?$166.8m$70.6m$81m53.4%

How much money is Ardelyx making?

Current yearPrevious yearGrowGrow %
Making money-$16.5m-$17m$538.2k3.3%
Net Profit Margin-96.1%-1,879.9%--

How much money comes from the company's main activities?

3. Financial Health of Ardelyx (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#283 / 1016

Most Revenue
#196 / 1016

Most Profit
#651 / 1016

Most Efficient
#571 / 1016

What can you expect buying and holding a share of Ardelyx? (5 min.)

Welcome investor! Ardelyx's management wants to use your money to grow the business. In return you get a share of Ardelyx.

What can you expect buying and holding a share of Ardelyx?

First you should know what it really means to hold a share of Ardelyx. And how you can make/lose money.

Speculation

The Price per Share of Ardelyx is $6.48. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ardelyx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ardelyx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.72. Based on the TTM, the Book Value Change Per Share is $0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.03 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ardelyx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.12-1.9%-0.07-1.1%-0.07-1.1%-0.10-1.6%-0.08-1.3%
Usd Book Value Change Per Share-0.10-1.6%0.071.1%0.020.3%0.010.2%0.020.3%
Usd Dividend Per Share0.111.7%0.030.4%0.000.0%0.010.1%0.000.0%
Usd Total Gains Per Share0.010.1%0.101.6%0.020.3%0.020.3%0.020.3%
Usd Price Per Share6.20-4.62-1.42-4.14-7.12-
Price to Earnings Ratio-12.52-0.34-2.25--6.07-303.53-
Price-to-Total Gains Ratio936.18-160.56-3.81-22.37-114.67-
Price to Book Ratio8.65-7.23-4.34-8.39-15.73-
Price-to-Total Gains Ratio936.18-160.56-3.81-22.37-114.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.48
Number of shares154
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.01
Usd Book Value Change Per Share0.070.01
Usd Total Gains Per Share0.100.02
Gains per Quarter (154 shares)15.612.55
Gains per Year (154 shares)62.4610.19
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1174552370
2349111471410
351136176102020
469181238142730
586227300173440
6103272362214150
7120317424244760
8137363486275470
9154408548316180
10171453610346890

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%2.018.00.010.0%6.034.00.015.0%6.038.01.013.3%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%7.013.00.035.0%15.025.00.037.5%15.027.03.033.3%
Dividend per Share1.00.03.025.0%2.00.010.016.7%2.00.018.010.0%2.00.038.05.0%2.00.043.04.4%
Total Gains per Share3.01.00.075.0%7.05.00.058.3%8.012.00.040.0%16.024.00.040.0%16.026.03.035.6%

Fundamentals of Ardelyx

About Ardelyx Inc

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation. It also develops XPHOZAH, which is in Phase III clinical trial to reduce serum phosphorus in adults with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia; RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among patients with kidney and/or heart failure; and RDX020, for adult patients with metabolic acidosis, a serious electrolyte disorder. The company has agreements with Kyowa Kirin, Fosun Pharmaceutical Industrial Development Co. Ltd., and Knight Therapeutics, Inc. for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-11 00:58:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Ardelyx Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ardelyx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ardelyx to the Biotechnology industry mean.
  • A Net Profit Margin of -83.8% means that $-0.84 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ardelyx Inc:

  • The MRQ is -83.8%. The company is making a huge loss. -2
  • The TTM is -96.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-83.8%TTM-96.1%+12.2%
TTM-96.1%YOY-1,879.9%+1,783.9%
TTM-96.1%5Y-9,922.8%+9,826.7%
5Y-9,922.8%10Y-8,012.8%-1,910.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-83.8%-199.6%+115.8%
TTM-96.1%-213.0%+116.9%
YOY-1,879.9%-279.3%-1,600.6%
5Y-9,922.8%-438.4%-9,484.4%
10Y-8,012.8%-605.5%-7,407.3%
1.1.2. Return on Assets

Shows how efficient Ardelyx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ardelyx to the Biotechnology industry mean.
  • -9.7% Return on Assets means that Ardelyx generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ardelyx Inc:

  • The MRQ is -9.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.7%TTM-7.0%-2.7%
TTM-7.0%YOY-13.3%+6.3%
TTM-7.0%5Y-13.7%+6.8%
5Y-13.7%10Y-11.3%-2.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.7%-13.5%+3.8%
TTM-7.0%-12.9%+5.9%
YOY-13.3%-11.8%-1.5%
5Y-13.7%-14.1%+0.4%
10Y-11.3%-16.0%+4.7%
1.1.3. Return on Equity

Shows how efficient Ardelyx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ardelyx to the Biotechnology industry mean.
  • -17.3% Return on Equity means Ardelyx generated $-0.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ardelyx Inc:

  • The MRQ is -17.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.3%TTM-12.3%-5.0%
TTM-12.3%YOY-29.8%+17.6%
TTM-12.3%5Y-26.0%+13.8%
5Y-26.0%10Y-18.2%-7.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.3%-16.9%-0.4%
TTM-12.3%-16.1%+3.8%
YOY-29.8%-15.1%-14.7%
5Y-26.0%-19.9%-6.1%
10Y-18.2%-20.9%+2.7%

1.2. Operating Efficiency of Ardelyx Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ardelyx is operating .

  • Measures how much profit Ardelyx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ardelyx to the Biotechnology industry mean.
  • An Operating Margin of -74.7% means the company generated $-0.75  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ardelyx Inc:

  • The MRQ is -74.7%. The company is operating very inefficient. -2
  • The TTM is -89.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-74.7%TTM-89.7%+15.0%
TTM-89.7%YOY-1,847.7%+1,758.0%
TTM-89.7%5Y-9,394.6%+9,304.9%
5Y-9,394.6%10Y-7,708.9%-1,685.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-74.7%-295.1%+220.4%
TTM-89.7%-225.8%+136.1%
YOY-1,847.7%-288.4%-1,559.3%
5Y-9,394.6%-477.4%-8,917.2%
10Y-7,708.9%-625.6%-7,083.3%
1.2.2. Operating Ratio

Measures how efficient Ardelyx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.81 means that the operating costs are $1.81 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ardelyx Inc:

  • The MRQ is 1.814. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.927. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.814TTM1.927-0.113
TTM1.927YOY19.477-17.550
TTM1.9275Y97.683-95.756
5Y97.68310Y97.585+0.099
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8143.090-1.276
TTM1.9273.264-1.337
YOY19.4773.783+15.694
5Y97.6835.679+92.004
10Y97.5857.894+89.691

1.3. Liquidity of Ardelyx Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ardelyx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.88 means the company has $4.88 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ardelyx Inc:

  • The MRQ is 4.884. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.926. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.884TTM3.926+0.958
TTM3.926YOY2.277+1.649
TTM3.9265Y5.250-1.324
5Y5.25010Y8.107-2.857
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8843.914+0.970
TTM3.9264.220-0.294
YOY2.2775.388-3.111
5Y5.2506.045-0.795
10Y8.1076.406+1.701
1.3.2. Quick Ratio

Measures if Ardelyx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ardelyx to the Biotechnology industry mean.
  • A Quick Ratio of 7.33 means the company can pay off $7.33 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ardelyx Inc:

  • The MRQ is 7.326. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.446. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.326TTM5.446+1.879
TTM5.446YOY2.436+3.011
TTM5.4465Y6.988-1.542
5Y6.98810Y10.161-3.173
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.3263.572+3.754
TTM5.4463.998+1.448
YOY2.4365.390-2.954
5Y6.9885.969+1.019
10Y10.1616.287+3.874

1.4. Solvency of Ardelyx Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ardelyx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ardelyx to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.44 means that Ardelyx assets are financed with 43.9% credit (debt) and the remaining percentage (100% - 43.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ardelyx Inc:

  • The MRQ is 0.439. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.404. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.439TTM0.404+0.035
TTM0.404YOY0.530-0.126
TTM0.4045Y0.433-0.029
5Y0.43310Y0.341+0.093
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4390.336+0.103
TTM0.4040.334+0.070
YOY0.5300.269+0.261
5Y0.4330.366+0.067
10Y0.3410.390-0.049
1.4.2. Debt to Equity Ratio

Measures if Ardelyx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ardelyx to the Biotechnology industry mean.
  • A Debt to Equity ratio of 78.4% means that company has $0.78 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ardelyx Inc:

  • The MRQ is 0.784. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.686. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.784TTM0.686+0.098
TTM0.686YOY1.148-0.463
TTM0.6865Y0.812-0.126
5Y0.81210Y0.560+0.252
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7840.382+0.402
TTM0.6860.396+0.290
YOY1.1480.335+0.813
5Y0.8120.434+0.378
10Y0.5600.465+0.095

2. Market Valuation of Ardelyx Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ardelyx generates.

  • Above 15 is considered overpriced but always compare Ardelyx to the Biotechnology industry mean.
  • A PE ratio of -12.52 means the investor is paying $-12.52 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ardelyx Inc:

  • The EOD is -13.088. Based on the earnings, the company is expensive. -2
  • The MRQ is -12.522. Based on the earnings, the company is expensive. -2
  • The TTM is 0.339. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-13.088MRQ-12.522-0.566
MRQ-12.522TTM0.339-12.861
TTM0.339YOY2.247-1.908
TTM0.3395Y-6.071+6.410
5Y-6.07110Y303.526-309.597
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-13.088-2.259-10.829
MRQ-12.522-2.569-9.953
TTM0.339-2.664+3.003
YOY2.247-4.120+6.367
5Y-6.071-6.258+0.187
10Y303.526-6.171+309.697
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ardelyx Inc:

  • The EOD is -43.026. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -41.167. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -17.910. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-43.026MRQ-41.167-1.859
MRQ-41.167TTM-17.910-23.257
TTM-17.910YOY1.413-19.323
TTM-17.9105Y-11.467-6.443
5Y-11.46710Y-23.684+12.218
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-43.026-2.924-40.102
MRQ-41.167-3.246-37.921
TTM-17.910-3.488-14.422
YOY1.413-5.620+7.033
5Y-11.467-8.315-3.152
10Y-23.684-8.826-14.858
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ardelyx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 8.65 means the investor is paying $8.65 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Ardelyx Inc:

  • The EOD is 9.039. Based on the equity, the company is overpriced. -1
  • The MRQ is 8.648. Based on the equity, the company is overpriced. -1
  • The TTM is 7.226. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD9.039MRQ8.648+0.391
MRQ8.648TTM7.226+1.422
TTM7.226YOY4.338+2.888
TTM7.2265Y8.393-1.166
5Y8.39310Y15.728-7.336
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD9.0391.851+7.188
MRQ8.6482.090+6.558
TTM7.2262.095+5.131
YOY4.3382.844+1.494
5Y8.3933.466+4.927
10Y15.7283.815+11.913
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Ardelyx Inc.

3.1. Institutions holding Ardelyx Inc

Institutions are holding 59.707% of the shares of Ardelyx Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31HHG PLC10.59750.091124658820-2623801-9.6171
2023-12-31State Street Corporation7.35010.005217102598397660230.2956
2023-12-31BlackRock Inc7.20970.002716776055234636716.2607
2023-12-31Vanguard Group Inc5.59810.001813026046146024612.6256
2023-12-31Eventide Asset Management, LLC2.92480.688768054944110494152.523
2023-12-31Geode Capital Management, LLC2.14680.0032499536253793012.0682
2023-12-31Rubric Capital Management LP1.72450.51624012753151275360.5101
2023-12-31Morgan Stanley - Brokerage Accounts1.37740.00183205108682252.1749
2023-12-31Adage Capital Partners Gp LLC1.11740.0334260000030000013.0435
2023-12-31Susquehanna International Group, LLP1.11290.0031258948225853211.0913
2023-12-31Amvescap Plc.1.00270.0034233312797014871.1785
2023-12-31T. Rowe Price Associates, Inc.1.0010.0019232926659709934.4712
2023-12-31Goldman Sachs Group Inc0.9490.0012220814093925774.0223
2023-12-31Northern Trust Corp0.94020.0025218781823164911.842
2023-12-31Barclays PLC0.93930.005218562029029315.3162
2023-12-31Nuveen Asset Management, LLC0.90590.004221078911712408.8421
2023-12-31Charles Schwab Investment Management Inc0.78080.002918167321504659.0301
2023-12-31J. Goldman & Co LP0.68730.40121599220682514.458
2023-12-31Rafferty Asset Management, LLC0.59110.036137551427762025.2866
2023-12-31Lion Point Capital, LP0.49493.57261151667-25000-2.1246
Total 49.45145.3781115066713+15618370+13.6%

3.2. Funds holding Ardelyx Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28SPDR® S&P Biotech ETF3.77860.8587921581109201.2777
2024-02-29Vanguard Total Stock Mkt Idx Inv3.04820.00437092678-21195-0.2979
2024-03-28iShares Russell 2000 ETF2.42530.0629564339927210.0482
2023-12-31Janus Henderson Triton D2.42410.5128564053076815615.7655
2023-12-31Janus Henderson US SMID Cap Growth2.42410.515564053076815615.7655
2023-12-31Janus Henderson Global Life Sciences2.12620.62624947362-39210-0.7863
2023-12-31Janus Henderson Global Life Sciences D2.12620.62334947362-39210-0.7863
2023-12-31Eventide Healthcare & Life Sciences I1.821.57524235000154000057.1429
2023-12-31Janus Selection Global Life Science AUSD1.60630.62663737691-105714-2.7505
2024-02-29Janus Henderson Glb Life Scn I2 USD1.55780.8491362481145230.1249
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.48260.03153449772-14801-0.4272
2023-12-31Eventide Gilead N1.10390.4162256854325685430
2024-01-31Fidelity Small Cap Index1.00330.08222334498360751.5696
2024-03-28Invesco Dorsey Wright SmallCap Momt ETF0.9311.3668216623000
2023-12-31T. Rowe Price Health Sciences0.72390.071168447516844750
2024-01-31TIAA-CREF Quant Small-Cap Equity Instl0.62510.4239145452000
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.59730.0311389800257001.884
2024-03-28iShares Russell 2000 Growth ETF0.56370.08221311676-1525-0.1161
2024-02-29Fidelity Extended Market Index0.56170.03181307099113610.8768
2024-02-29DWS ESG Biotech LC0.52042.81081210929-2-0.0002
Total 31.449711.592873179063+7298973+10.0%

3.3. Insider Transactions

Insiders are holding 1.878% of the shares of Ardelyx Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-01Michael RaabSELL15187.31
2024-03-20Elizabeth A GrammerSELL860007.73
2024-02-26David P RosenbaumSELL51839.2
2024-02-20Justin A RenzSELL53418.75
2024-02-20Michael RaabSELL229178.75
2024-02-20Robert BlanksSELL50178.75
2024-02-08David P RosenbaumSELL153449.18
2024-01-08David P RosenbaumSELL300006.64
2023-12-26Justin A RenzSELL2250006.36
2023-12-18David P RosenbaumSELL56756.07
2023-12-14David P RosenbaumSELL70005.55
2023-12-11Elizabeth A GrammerSELL500005.08
2023-12-08David P RosenbaumSELL200005.27
2023-12-05David P RosenbaumSELL102725
2023-11-30David P RosenbaumSELL30004.5
2023-11-20Justin A RenzSELL28734.36
2023-11-20Michael RaabSELL113684.36
2023-11-20Laura A WilliamsSELL25814.36
2023-11-15Laura A WilliamsSELL250004
2023-10-10David P RosenbaumSELL16444

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Ardelyx Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1050.074-242%0.017-720%0.011-1055%0.019-659%
Book Value Per Share--0.7170.652+10%0.303+136%0.488+47%0.509+41%
Current Ratio--4.8843.926+24%2.277+114%5.250-7%8.107-40%
Debt To Asset Ratio--0.4390.404+9%0.530-17%0.433+1%0.341+29%
Debt To Equity Ratio--0.7840.686+14%1.148-32%0.812-3%0.560+40%
Dividend Per Share--0.1110.028+300%0.000+124652%0.006+1894%0.003+3887%
Eps---0.124-0.071-43%-0.072-42%-0.103-17%-0.084-32%
Free Cash Flow Per Share---0.038-0.097+157%-0.076+103%-0.102+171%-0.083+121%
Free Cash Flow To Equity Per Share--0.0740.060+23%0.005+1526%0.002+3843%0.015+388%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.678--------
Intrinsic Value_10Y_min---4.582--------
Intrinsic Value_1Y_max---0.295--------
Intrinsic Value_1Y_min---0.456--------
Intrinsic Value_3Y_max---0.712--------
Intrinsic Value_3Y_min---1.381--------
Intrinsic Value_5Y_max---0.922--------
Intrinsic Value_5Y_min---2.311--------
Market Cap1507805280.000+4%1442653200.0001073845890.000+34%331571732.850+335%963318876.570+50%1656781909.785-13%
Net Profit Margin---0.838-0.961+15%-18.799+2143%-99.228+11739%-80.128+9460%
Operating Margin---0.747-0.897+20%-18.477+2374%-93.946+12479%-77.089+10222%
Operating Ratio--1.8141.927-6%19.477-91%97.683-98%97.585-98%
Pb Ratio9.039+4%8.6487.226+20%4.338+99%8.393+3%15.728-45%
Pe Ratio-13.088-5%-12.5220.339-3795%2.247-657%-6.071-52%303.526-104%
Price Per Share6.480+4%6.2004.615+34%1.425+335%4.140+50%7.120-13%
Price To Free Cash Flow Ratio-43.026-5%-41.167-17.910-56%1.413-3014%-11.467-72%-23.684-42%
Price To Total Gains Ratio978.459+4%936.180160.563+483%3.807+24494%22.370+4085%114.672+716%
Quick Ratio--7.3265.446+35%2.436+201%6.988+5%10.161-28%
Return On Assets---0.097-0.070-28%-0.133+37%-0.137+42%-0.113+17%
Return On Equity---0.173-0.123-29%-0.298+73%-0.260+51%-0.182+5%
Total Gains Per Share--0.0070.101-93%0.017-61%0.017-60%0.021-69%
Usd Book Value--166816000.000151639750.000+10%70605500.000+136%113462000.000+47%118544900.000+41%
Usd Book Value Change Per Share---0.1050.074-242%0.017-720%0.011-1055%0.019-659%
Usd Book Value Per Share--0.7170.652+10%0.303+136%0.488+47%0.509+41%
Usd Dividend Per Share--0.1110.028+300%0.000+124652%0.006+1894%0.003+3887%
Usd Eps---0.124-0.071-43%-0.072-42%-0.103-17%-0.084-32%
Usd Free Cash Flow---8761000.000-22515250.000+157%-17775500.000+103%-23707450.000+171%-19335800.000+121%
Usd Free Cash Flow Per Share---0.038-0.097+157%-0.076+103%-0.102+171%-0.083+121%
Usd Free Cash Flow To Equity Per Share--0.0740.060+23%0.005+1526%0.002+3843%0.015+388%
Usd Market Cap1507805280.000+4%1442653200.0001073845890.000+34%331571732.850+335%963318876.570+50%1656781909.785-13%
Usd Price Per Share6.480+4%6.2004.615+34%1.425+335%4.140+50%7.120-13%
Usd Profit---28802000.000-16516750.000-43%-17055000.000-41%-24085250.000-16%-19564050.000-32%
Usd Revenue--34363000.00031114000.000+10%13039500.000+164%9982400.000+244%8551825.000+302%
Usd Total Gains Per Share--0.0070.101-93%0.017-61%0.017-60%0.021-69%
 EOD+6 -2MRQTTM+22 -13YOY+26 -95Y+24 -1110Y+21 -14

4.2. Fundamental Score

Let's check the fundamental score of Ardelyx Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-13.088
Price to Book Ratio (EOD)Between0-19.039
Net Profit Margin (MRQ)Greater than0-0.838
Operating Margin (MRQ)Greater than0-0.747
Quick Ratio (MRQ)Greater than17.326
Current Ratio (MRQ)Greater than14.884
Debt to Asset Ratio (MRQ)Less than10.439
Debt to Equity Ratio (MRQ)Less than10.784
Return on Equity (MRQ)Greater than0.15-0.173
Return on Assets (MRQ)Greater than0.05-0.097
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Ardelyx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.951
Ma 20Greater thanMa 507.166
Ma 50Greater thanMa 1008.183
Ma 100Greater thanMa 2007.600
OpenGreater thanClose6.390
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -5434-20-190-2109-201425224



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets297,579
Total Liabilities130,763
Total Stockholder Equity166,816
 As reported
Total Liabilities 130,763
Total Stockholder Equity+ 166,816
Total Assets = 297,579

Assets

Total Assets297,579
Total Current Assets246,111
Long-term Assets51,468
Total Current Assets
Cash And Cash Equivalents 21,470
Short-term Investments 162,829
Net Receivables 22,031
Inventory 12,448
Other Current Assets 8,408
Total Current Assets  (as reported)246,111
Total Current Assets  (calculated)227,186
+/- 18,925
Long-term Assets
Property Plant Equipment 6,598
Long-term Assets Other 44,870
Long-term Assets  (as reported)51,468
Long-term Assets  (calculated)51,468
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities50,393
Long-term Liabilities80,370
Total Stockholder Equity166,816
Total Current Liabilities
Short-term Debt 4,435
Accounts payable 11,138
Other Current Liabilities 27,638
Total Current Liabilities  (as reported)50,393
Total Current Liabilities  (calculated)43,211
+/- 7,182
Long-term Liabilities
Long term Debt 49,822
Capital Lease Obligations 6,160
Long-term Liabilities  (as reported)80,370
Long-term Liabilities  (calculated)55,982
+/- 24,388
Total Stockholder Equity
Common Stock23
Retained Earnings -846,204
Accumulated Other Comprehensive Income 224
Other Stockholders Equity 1,012,773
Total Stockholder Equity (as reported)166,816
Total Stockholder Equity (calculated)166,816
+/-0
Other
Capital Stock23
Cash and Short Term Investments 184,299
Common Stock Shares Outstanding 219,331
Current Deferred Revenue7,182
Liabilities and Stockholders Equity 297,579
Net Debt 34,512
Net Invested Capital 216,638
Net Working Capital 195,718
Property Plant and Equipment Gross 16,799
Short Long Term Debt Total 55,982



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
37,884
0
0
0
42,904
40,548
123,478
117,729
113,414
105,399
148,188
138,066
116,946
180,498
155,379
241,317
213,131
187,765
164,122
143,105
157,903
142,837
228,536
206,668
183,332
166,135
137,980
119,410
259,782
235,322
217,343
198,555
201,562
210,293
204,982
170,848
149,913
129,408
131,610
144,672
190,066
217,019
211,203
289,379
297,579
297,579289,379211,203217,019190,066144,672131,610129,408149,913170,848204,982210,293201,562198,555217,343235,322259,782119,410137,980166,135183,332206,668228,536142,837157,903143,105164,122187,765213,131241,317155,379180,498116,946138,066148,188105,399113,414117,729123,47840,54842,90400037,884
   > Total Current Assets 
0
0
0
0
41,836
39,115
122,147
116,373
111,283
101,906
143,923
133,471
112,235
175,697
150,404
234,200
203,992
178,008
153,945
133,630
149,871
135,320
221,688
199,322
177,721
154,312
127,241
110,834
252,376
228,582
211,626
193,793
195,238
205,376
186,492
153,379
134,799
114,225
114,107
119,875
154,484
167,047
162,118
241,216
246,111
246,111241,216162,118167,047154,484119,875114,107114,225134,799153,379186,492205,376195,238193,793211,626228,582252,376110,834127,241154,312177,721199,322221,688135,320149,871133,630153,945178,008203,992234,200150,404175,697112,235133,471143,923101,906111,283116,373122,14739,11541,8360000
       Cash And Cash Equivalents 
32,903
0
0
0
34,435
33,221
117,814
112,044
107,286
98,318
141,534
129,047
107,004
171,678
146,669
160,360
74,598
71,213
63,636
59,454
75,383
67,745
91,751
75,015
78,768
92,036
89,626
92,673
181,133
105,895
100,494
91,009
91,032
84,070
86,745
75,288
72,428
47,077
53,408
61,628
96,140
92,487
30,058
33,767
21,470
21,47033,76730,05892,48796,14061,62853,40847,07772,42875,28886,74584,07091,03291,009100,494105,895181,13392,67389,62692,03678,76875,01591,75167,74575,38359,45463,63671,21374,598160,360146,669171,678107,004129,047141,53498,318107,286112,044117,81433,22134,43500032,903
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
69,726
126,225
102,210
85,088
69,834
58,593
59,704
120,980
111,391
89,321
59,524
34,315
10,870
66,379
117,312
104,347
94,488
95,452
94,142
85,064
66,363
44,261
42,627
27,604
28,995
27,769
37,886
97,521
131,313
162,829
162,829131,31397,52137,88627,76928,99527,60442,62744,26166,36385,06494,14295,45294,488104,347117,31266,37910,87034,31559,52489,321111,391120,98059,70458,59369,83485,088102,210126,22569,726000000000000000
       Net Receivables 
0
0
0
0
6,436
4,977
3,025
2,660
2,584
2,043
27
0
0
0
0
0
0
0
0
0
10,796
5,000
5,030
5,167
5,085
7
17
2,699
750
750
750
750
0
5,783
0
287
502
4,394
5,623
5,208
7,733
12,120
9,109
43,263
22,031
22,03143,2639,10912,1207,7335,2085,6234,39450228705,78307507507507502,6991775,0855,1675,0305,00010,796000000000272,0432,5842,6603,0254,9776,4360000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,487
4,529
1,250
3,282
4,823
7,617
8,524
12,448
12,4488,5247,6174,8233,2821,2504,5293,4870000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
1,068
1,433
1,331
1,356
2,131
3,493
4,265
4,595
4,711
4,801
4,975
7,117
9,139
9,757
10,177
9,475
8,032
7,517
6,848
7,346
5,611
11,823
10,739
8,576
7,406
6,740
5,717
4,762
6,324
4,917
18,490
17,469
15,114
15,183
17,503
24,797
35,582
49,972
49,085
48,163
51,468
51,46848,16349,08549,97235,58224,79717,50315,18315,11417,46918,4904,9176,3244,7625,7176,7407,4068,57610,73911,8235,6117,3466,8487,5178,0329,47510,1779,7579,1397,1174,9754,8014,7114,5954,2653,4932,1311,3561,3311,4331,0680000
       Property Plant Equipment 
844
0
0
0
530
551
1,138
1,152
2,131
3,289
4,061
4,391
4,711
4,597
4,827
6,969
8,991
8,915
9,335
8,622
8,032
7,358
6,689
5,996
5,611
10,473
9,388
8,396
7,406
6,436
5,446
4,513
4,210
3,959
17,185
16,231
15,114
13,955
12,595
11,476
10,518
9,074
8,117
7,639
6,598
6,5987,6398,1179,07410,51811,47612,59513,95515,11416,23117,1853,9594,2104,5135,4466,4367,4068,3969,38810,4735,6115,9966,6897,3588,0328,6229,3358,9158,9916,9694,8274,5974,7114,3914,0613,2892,1311,1521,138551530000844
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,114
0
0
0
0
0
0
0
0
0
0
0
0
0000000000002,11400000000000000000000000000000000
       Long-term Assets Other 
0
0
0
0
538
882
193
204
204
204
204
204
204
204
148
148
148
842
842
853
159
159
159
1,350
1,350
1,350
1,351
180
314
304
271
249
552
958
1,305
1,238
1,150
1,228
4,908
13,321
25,064
40,898
40,968
40,524
44,870
44,87040,52440,96840,89825,06413,3214,9081,2281,1501,2381,3059585522492713043141801,3511,3501,3501,3501591591598538428421481481482042042042042042042041938825380000
> Total Liabilities 
39,121
0
0
0
50,228
41,792
60,611
54,428
52,732
47,399
5,928
12,936
8,045
12,750
14,774
18,424
19,980
20,081
19,144
16,468
18,591
13,861
65,122
65,220
67,519
74,294
69,363
70,252
73,127
67,565
70,993
67,215
75,450
79,482
87,413
89,416
67,296
65,218
78,568
77,811
91,737
91,598
88,042
98,218
130,763
130,76398,21888,04291,59891,73777,81178,56865,21867,29689,41687,41379,48275,45067,21570,99367,56573,12770,25269,36374,29467,51965,22065,12213,86118,59116,46819,14420,08119,98018,42414,77412,7508,04512,9365,92847,39952,73254,42860,61141,79250,22800039,121
   > Total Current Liabilities 
16,791
0
0
0
17,139
18,768
27,334
19,397
5,557
19,912
5,546
12,584
7,723
12,458
14,061
17,635
19,201
19,314
18,388
15,727
17,871
13,162
15,609
15,549
17,728
20,826
16,333
17,679
22,220
23,417
33,650
16,534
28,416
41,790
57,785
68,768
57,548
47,843
48,699
51,951
74,628
63,063
61,689
43,529
50,393
50,39343,52961,68963,06374,62851,95148,69947,84357,54868,76857,78541,79028,41616,53433,65023,41722,22017,67916,33320,82617,72815,54915,60913,16217,87115,72718,38819,31419,20117,63514,06112,4587,72312,5845,54619,9125,55719,39727,33418,76817,13900016,791
       Short-term Debt 
0
0
0
0
0
0
0
0
-15,979
0
0
0
0
0
0
0
0
0
0
0
0
0
10,891
11,678
-585
2,102
2,318
2,504
3,791
10,152
16,542
2,770
6,284
18,079
39,295
47,835
35,756
29,731
30,064
30,332
30,605
30,878
31,157
4,321
4,435
4,4354,32131,15730,87830,60530,33230,06429,73135,75647,83539,29518,0796,2842,77016,54210,1523,7912,5042,3182,102-58511,67810,8910000000000000-15,97900000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,836
0
0
2,102
0
0
1,183
7,437
13,716
0
4,167
16,667
36,111
44,444
32,264
26,139
26,373
26,541
26,711
26,880
27,052
0
0
0027,05226,88026,71126,54126,37326,13932,26444,44436,11116,6674,167013,7167,4371,183002,1020048,8360000000000000000000000
       Accounts payable 
1,146
0
0
0
2,284
2,530
2,308
1,022
3,129
2,544
2,684
2,714
2,777
4,875
4,746
6,298
5,635
5,893
4,713
1,723
17,871
1,761
3,172
2,269
16,728
2,925
1,260
2,689
2,187
1,012
4,212
2,490
5,626
5,378
2,587
4,263
4,277
5,030
4,294
3,113
10,859
10,513
5,294
7,736
11,138
11,1387,7365,29410,51310,8593,1134,2945,0304,2774,2632,5875,3785,6262,4904,2121,0122,1872,6891,2602,92516,7282,2693,1721,76117,8711,7234,7135,8935,6356,2984,7464,8752,7772,7142,6842,5443,1291,0222,3082,5302,2840001,146
       Other Current Liabilities 
15,645
0
0
0
1,027
1,263
1,805
1,895
2,428
1,415
2,862
9,870
4,946
7,583
9,315
11,337
13,566
13,421
13,675
14,004
13,938
10,401
546
602
585
570
594
779
11,701
8,887
10,655
10,389
12,329
15,610
14,491
16,143
12,788
4,519
1,920
14,503
19,928
16,127
19,279
27,400
27,638
27,63827,40019,27916,12719,92814,5031,9204,51912,78816,14314,49115,61012,32910,38910,6558,88711,70177959457058560254610,40113,93814,00413,67513,42113,56611,3379,3157,5834,9469,8702,8621,4152,4281,8951,8051,2631,02700015,645
   > Long-term Liabilities 
0
0
0
0
33,089
23,024
33,277
35,031
47,175
27,487
382
352
322
292
713
789
779
767
756
741
720
699
49,513
49,671
49,791
53,468
53,030
52,573
50,907
44,148
37,343
50,681
47,034
37,692
29,628
20,648
9,748
17,375
29,869
25,860
17,109
28,535
26,353
54,689
80,370
80,37054,68926,35328,53517,10925,86029,86917,3759,74820,64829,62837,69247,03450,68137,34344,14850,90752,57353,03053,46849,79149,67149,51369972074175676777978971329232235238227,48747,17535,03133,27723,02433,0890000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,836
49,020
49,209
49,399
49,597
49,803
48,831
42,793
36,735
50,681
46,621
34,348
15,133
0
0
0
0
0
0
0
0
0
0
000000000015,13334,34846,62150,68136,73542,79348,83149,80349,59749,39949,20949,02048,8360000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
15,979
0
0
0
0
0
0
0
0
0
0
0
0
0
-10,891
-11,678
585
4,069
3,433
2,770
893
-6,082
-13,108
0
-3,754
-16,270
-24,563
-33,775
-22,516
-17,327
-18,516
-19,663
-20,856
-22,066
-23,300
2,887
1,725
1,7252,887-23,300-22,066-20,856-19,663-18,516-17,327-22,516-33,775-24,563-16,270-3,7540-13,108-6,0828932,7703,4334,069585-11,678-10,891000000000000015,97900000000
       Long-term Liabilities Other 
0
0
0
0
0
0
107
72
122
297
382
352
322
292
713
789
779
767
756
741
0
699
677
651
0
4,069
3,433
2,770
2,076
1,355
608
0
413
3,344
14,495
0
14,475
17,375
0
25,860
17,109
28,535
26,353
170
0
017026,35328,53517,10925,860017,37514,475014,4953,34441306081,3552,0762,7703,4334,0690651677699074175676777978971329232235238229712272107000000
       Deferred Long Term Liability 
0
0
0
0
0
0
33,170
34,959
31,074
27,190
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000027,19031,07434,95933,170000000
> Total Stockholder Equity
0
0
0
0
-7,324
-1,244
62,867
63,301
60,682
58,000
142,260
125,130
108,901
167,748
140,605
222,893
193,151
167,684
144,978
126,637
139,312
128,976
163,414
141,448
115,813
91,841
68,617
49,158
186,655
167,757
146,350
131,340
126,112
130,811
117,569
81,432
82,617
64,190
53,042
66,861
98,329
125,421
123,161
191,161
166,816
166,816191,161123,161125,42198,32966,86153,04264,19082,61781,432117,569130,811126,112131,340146,350167,757186,65549,15868,61791,841115,813141,448163,414128,976139,312126,637144,978167,684193,151222,893140,605167,748108,901125,130142,26058,00060,68263,30162,867-1,244-7,3240000
   Common Stock
0
0
0
0
0
1
2
2
2
3
3
3
3
4
4
5
5
5
5
5
5
5
6
6
6
6
6
6
9
9
9
9
9
10
10
11
13
14
15
19
20
21
22
23
23
232322212019151413111010999996666665555555443333222100000
   Retained Earnings Total Equity00-824,031-806,910-780,137-790,832-767,939-741,001-712,9300-633,109-587,920-554,765-525,889-507,781-482,825-460,452-440,662-417,123-391,656-365,512-337,650-313,524-291,232-278,214-288,328-267,604-241,883-213,875-182,601-153,570-124,955-101,488-84,488-66,362-75,369-71,867-67,896-67,971000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-3,332
0
-123,478
-117,729
-3,634
-3,634
0
0
-3,808
-3,808
0
-25
-71
-48
-40
-10
-47
-91
-36
-17
-38
12
16
4
20
-44
317
90
-4
-7
4
3
-6
-88
-109
-114
-54
-20
-210
-201
224
224-201-210-20-54-114-109-88-634-7-490317-442041612-38-17-36-91-47-10-40-48-71-250-3,808-3,80800-3,634-3,634-117,729-123,4780-3,3320000
   Capital Surplus 
0
0
0
0
0
0
130,836
131,195
132,547
133,366
208,619
209,615
210,386
292,699
294,171
405,514
407,092
409,610
412,617
414,970
417,568
420,294
476,968
479,109
481,357
483,479
485,718
489,810
647,078
650,617
653,805
657,130
680,872
718,728
750,664
0
795,540
805,265
821,075
857,788
878,500
932,330
947,380
0
0
00947,380932,330878,500857,788821,075805,265795,5400750,664718,728680,872657,130653,805650,617647,078489,810485,718483,479481,357479,109476,968420,294417,568414,970412,617409,610407,092405,514294,171292,699210,386209,615208,619133,366132,547131,195130,836000000
   Treasury Stock000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
8,506
70,479
130,836
131,195
136,181
133,366
208,619
209,615
214,194
292,699
294,171
405,514
407,092
409,610
412,617
414,970
417,568
420,294
476,968
479,109
481,357
483,479
485,718
489,810
647,078
650,617
653,805
657,130
680,872
718,728
750,664
758,114
795,540
805,265
821,075
857,788
878,500
932,330
947,380
1,008,741
1,012,773
1,012,7731,008,741947,380932,330878,500857,788821,075805,265795,540758,114750,664718,728680,872657,130653,805650,617647,078489,810485,718483,479481,357479,109476,968420,294417,568414,970412,617409,610407,092405,514294,171292,699214,194209,615208,619133,366136,181131,195130,83670,4798,5060000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue124,456
Cost of Revenue-17,795
Gross Profit106,661106,661
 
Operating Income (+$)
Gross Profit106,661
Operating Expense-169,937
Operating Income-63,276-63,276
 
Operating Expense (+$)
Research Development35,536
Selling General Administrative134,401
Selling And Marketing Expenses0
Operating Expense169,937169,937
 
Net Interest Income (+$)
Interest Income0
Interest Expense-8,874
Other Finance Cost-0
Net Interest Income-8,874
 
Pretax Income (+$)
Operating Income-63,276
Net Interest Income-8,874
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-65,520-69,906
EBIT - interestExpense = -65,520
-65,520
-57,193
Interest Expense8,874
Earnings Before Interest and Taxes (EBIT)-56,646-56,646
Earnings Before Interest and Taxes (EBITDA)-55,354
 
After tax Income (+$)
Income Before Tax-65,520
Tax Provision-547
Net Income From Continuing Ops-66,067-66,067
Net Income-66,067
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses187,732
Total Other Income/Expenses Net6,6308,874
 

Technical Analysis of Ardelyx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ardelyx. The general trend of Ardelyx is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ardelyx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ardelyx Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.87 < 7.905 < 8.16.

The bearish price targets are: 5.92 > 5.125 > 4.97.

Tweet this
Ardelyx Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ardelyx Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ardelyx Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ardelyx Inc. The current macd is -0.43420892.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ardelyx price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ardelyx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ardelyx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Ardelyx Inc Daily Moving Average Convergence/Divergence (MACD) ChartArdelyx Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ardelyx Inc. The current adx is 29.84.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ardelyx shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Ardelyx Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ardelyx Inc. The current sar is 7.35854023.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Ardelyx Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ardelyx Inc. The current rsi is 29.95. The current phase is Oversold in neutral market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in neutral market:
  • Trending up: The RSI is trending up. +1
Ardelyx Inc Daily Relative Strength Index (RSI) ChartArdelyx Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ardelyx Inc. The current phase is Oversold in neutral market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ardelyx price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Ardelyx Inc Daily Stochastic Oscillator ChartArdelyx Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ardelyx Inc. The current cci is -172.19371784.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Ardelyx Inc Daily Commodity Channel Index (CCI) ChartArdelyx Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ardelyx Inc. The current cmo is -48.84640952.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Ardelyx Inc Daily Chande Momentum Oscillator (CMO) ChartArdelyx Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ardelyx Inc. The current willr is -86.875.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Ardelyx Inc Daily Williams %R ChartArdelyx Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ardelyx Inc.

Ardelyx Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ardelyx Inc. The current atr is 0.39154647.

Ardelyx Inc Daily Average True Range (ATR) ChartArdelyx Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ardelyx Inc. The current obv is 511,191,452.

Ardelyx Inc Daily On-Balance Volume (OBV) ChartArdelyx Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ardelyx Inc. The current mfi is 26.90.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Ardelyx Inc Daily Money Flow Index (MFI) ChartArdelyx Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ardelyx Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Ardelyx Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ardelyx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.951
Ma 20Greater thanMa 507.166
Ma 50Greater thanMa 1008.183
Ma 100Greater thanMa 2007.600
OpenGreater thanClose6.390
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ardelyx with someone you think should read this too:
  • Are you bullish or bearish on Ardelyx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ardelyx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ardelyx Inc

I send you an email if I find something interesting about Ardelyx Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Ardelyx Inc.

Receive notifications about Ardelyx Inc in your mailbox!